One of the most awaited vaccines by humanity is certainly the cancer vaccine. However, thanks to science, what was considered something almost from another world is now closer to reality. Last week, the City of Hope cancer research and treatment center announced the first trial of a cancer vaccine. It represents a great achievement for science and medicine.
Follow the text and learn more!
see more
Gene therapy eye drops bring hope to millions of people…
Better Health in Two Days: The Surprising Effectiveness of End Workouts…
See too: Moderna to launch two more vaccines soon
The vaccine, or medicine, is known by the scientific name CF33-hNIS, but its popular name is Vaccinia. It is basically a substance from a genetically modified virus. Thus, it is designed to specifically infect and kill cancer cells.
In this sense, after being applied to the body, the vaccine enters the infected cells and duplicates itself. Then they explode and release new viral particles, known as antigens, capable of stimulating the immune system to fight cancer cells. These new possibilities are of great value to medicine. After all, with the expansion of treatment models, the speed of results and the quality of life of many people will increase considerably.
Cancer vaccines are at their potential study level, and have already been tested in prostate, breast and skin cancers. With satisfactory results, the drug industry has bet all its chips on this new branch that promises to be very promising.
What differs them from other vaccines is the need for personalization of treatment. This complicates the production process, as in addition to increasing the price, its large-scale production is prohibited. However, scientists are optimistic about the results and hope that these vaccines will be a gateway to the discovery of immunizations and drugs for other diseases. Thus, they can be produced on a large scale and help in the treatment of many patients.
